2044
S. Carballares et al. / Tetrahedron Letters 48 (2007) 2041–2045
H
R2
N
R1
R2
N+
N
ii
i
N
N
H
+
NH2
R1
N
C
N
N
N
ref 11
R2
N
N
OHC R1
Scheme 3. Reagents and conditions: (i) toluene, NH4Cl, 120 °C, 24–48 h; (ii) (a) MeOH/DCM 1:4 (0.3 M), Sc(OTf)3 0.05 equiv, 65 °C; (b) NaOH 5%
H2O/MeOH 1:4, 80 °C.
at 65 °C.14 A crude mixture is treated with NaOH/
hedron 2002, 58, 4445; (e) Lee, Y. S.; Lee, K-J. Bull.
Korean Chem. Soc. 2002, 23, 1845; (f) Nadipuram, A.;
MeOH/H2O at 80 °C for 3 h to yield, in most cases, only
Kerwin, S. Tetrahedron 2006, 62, 3798; (g) Kolar, P.;
regioisomer b in yields higher than 90% usually with-
Pizzioli, A.; Tisler, M. J. Heterocycl. Chem. 1996, 33,
out requiring purification.15 In some cases, pure starting
639.
materials were used for the rearrangement step (Table
3. For some examples of nitration at C-3 see: Roubaud, C.;
2).
Vanelle, P.; Maldonado, J.; Crozet, M. P. Tetrahedron
1995, 51, 9643; Yveline, R.; Gerard, G.; Georges, M.
Chem. Pharm. Bull. 1992, 40, 1170.
4. (a) Groebke, K.; Weber, L.; Mehlin, F. Synlett 1998, 661;
Interestingly, the reaction can be expanded to com-
pounds bearing a free –NH2 group. When the commer-
cially available compound 11a is treated under the
same conditions, 11b is formed as the only regio-
isomer quantitatively. It seems that the selectivity in
the cyclization step (see Scheme 1) is not only driven
by the steric effects, but also by the different electronic
pattern of the imidazole intermediate due the presence
of an amino group at C-3 (Scheme 2). The correct iden-
tity of compound as 2-amino imidazo[1,2-a]pyrimidines
´
(b) Bienayme, H.; Bouzid, K. Angew. Chem., Int. Ed. 1998,
37, 2234; (c) Blackburn, C.; Guan, B.; Fleming, P.;
Shiosaki, K.; Tsai, S. Tetrahedron Lett. 1998, 39, 3635.
5. Kiselyov, A. Tetrahedron Lett. 2005, 46, 4487.
6. (a) Bristow, N. W.; Charlton, P. T.; Peak, D. A.; Short, W.
F. J. Chem. Soc. 1954, 616–629; (b) Tadeka, K.; Shudo,
K.; Okamoto, T.; Kousuge, T. Chem. Pharm. Bull. 1978,
26, 2924; (c) Knott, E. B. J. Chem. Soc. 1956, 1360; (d)
Sugiura, S.; Akoi, H. K.; Inouf, S.; Goto, T. Yakukagaku
Zasshi 1970, 90, 436; (e) Saint-Ruf, G.; Loukakou, B.;
Zousi, C. J. Heterocycl. Chem. 1981, 18, 1565–1570; (f)
Ohta, M.; Masaki, M. Bull. Chem. Soc. Jpn. 1960, 37,
1392.
1
was confirmed by LCMS analysis, H NMR, by com-
parison with those compounds already characterized
by Krasavin and co-workers11 and finally, by the X-ray
structure of some representative products (1b, Fig. 2).
7. Katritzky, A.; Xu, Y.; Tu, H. J. Org. Chem. 2003, 68,
4935.
In summary, we have developed a new way to prepare 2-
aminoimidazopyrimidines by a selective rearrangement.
The process has been tested in a great variety of prod-
ucts including free amino groups, which indicates the
broad scope of the reaction. The process can be coupled
to an isocyanide MCR affording a very versatile process
for the rapid synthesis of 2-aminoimidazopyrimidines
(Scheme 3).
8. (a) Bochis, R.; Olen, L.; Fisher, M. H.; Reaner, R. A. J.
Med. Chem. 1981, 24, 1483; (b) Hamdouchi, C.; Zhong,
B.; Mendoza, J.; Collins, E.; Jaramillo, C.; de Diego, J. E.;
Robertson, D.; Spencer, C. D.; Anderson, B.; Watkins, S.
A.; Zhang, F.; Brooks, H. Bioorg. Med. Chem. Lett. 2005,
15, 1943; (c) Jaramillo, C.; Carretero, J. C.; de Diego, J.
E.; del Prado, M.; Hamdouchi, C.; Roldan, J. L.; Sanchez-
Martinez, C. Tetrahedron Lett. 2002, 43, 9051; (d) Acero-
Alarcon, A.; Armero-Alart, T.; Jorda-Gregori, J. M.;
Rojas-Arguo, C.; Zaballos-Garcia, E.; Server-Carrio, J.;
Ahjyaje, F. Z.; Sepu´lveda-Arques, J. Synthesis 1999, 12,
2124; (e) Hamdouchi, C.; de Blas, J.; del Prado, M.;
Gruber, J.; Heinz, B. A.; Vance, L. J. Med. Chem. 1999,
42, 50; (f) Hamdouchi, C.; Sanchez-Martinez, C.; Ezqu-
erra, J. Synthesis 1998, 867; (g) Hamdouchi, C.; de Blas, J.;
Ezquerra, J. Tetrahedron 1999, 55, 541.
9. N-Alkylation of 2-halopyridines have been also used for
the preparation of 2-aminoimidazo[1,2-a]pyridines, but it
has not been applied successfully in the case of pyrimi-
dines: (a) Vega, J.; Vaquero, J.; Alvarez-Builla, J.;
Ezquerra, J.; Hamdouchi, C. Tetrahedron 1999, 55, 2317;
(b) Jaramillo, C.; de Diego, J. E.; Hamdouchi, C. Synlett
2002, 1544.
10. Mandair, G. S.; Light, M.; Russell, A.; Hursthouse, M.;
Bradley, M. Tetrahedron Lett. 2002, 43, 4267.
11. Parchinsky, V.; Shuvalova, O.; Ushakova, O.; Kra-
vchenko, D.; Krasavin, M. Tetrahedron Lett. 2006, 47,
947.
12. (a) Jacquier, R.; Lopez, H.; Mary, G. J. Heterocycl. Chem.
1973, 755; (b) Guerret, P.; Jacquier, R.; Maury, G. J.
Heterocycl. Chem. 1971, 643; (c) Jensen, M. S.; Hoerrner,
R. S.; Li, W.; Nelson, D. P.; Javadi, G. J.; Dormer, P. G.;
Cai, D.; Larsen, D. R. J. Org. Chem. 2005, 70, 6034; (d)
Chezal, J. M.; Moreau, E.; Delmas, G.; Gueiffier, A.;
References and notes
1. (a) Trapini, G.; Franco, M.; Latrofa, A.; Ricciardi, L.;
Carotti, A.; Serra, M.; Sanna, E.; Biggio, G.; Liso, G.
J. Med. Chem. 1999, 42, 3934; (b) Lober, S.; Hubner, H.;
Gmeneir, P. Bioorg. Med. Chem. Lett. 1999, 42, 3934; (c)
Rival, Y.; Grassy, G.; Michel, G. Chem. Pharm. Bull.
1992, 40, 1170; (d) Lyon, M.; Kercker, T. Org. Lett. 2004,
26, 4989; (e) Jaramillo, C.; Carretero, C.; de Diego, E.;
Hamoduchi, C.; del Prado, M.; Roldan, J. L.; Sanchez-
Martinez, C. Tetrahedron Lett. 2002, 43, 9051; (f)
Kaminski, J. J.; Wallmark, B.; Briving, C.; Andersson,
B. M. J. Med. Chem. 1991, 34, 533; (g) Georges, G.;
Vercauteren, D. P.; Vanderveken, D. J.; Horion, R.;
Evrard, G. H.; Durant, F. V.; George, P.; Wick, A. Eur. J.
Med. Chem. 1993, 28, 323.
2. For less common methods of synthesis of imidazopyri-
dines see: (a) Moutou, J.; Schmitt, M.; Collot, V.;
Bourguignon, J. Tetrahedron Lett. 1996, 37, 1787; (b)
Knolker, H.; Hitzemann, R. Tetrahedron Lett. 1994, 35,
2157; (c) Jeffrey, D.; Prager, R.; Turner, D.; Dreimanis,
M. Tetrahedron 2002, 58, 9965; (d) Baso, D.; Broggini, G.;
Passarella, D.; Pilati, T.; Terraneo, A.; Zecchi, G. Tetra-